Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. 1994

R Dagan, and L Velghe, and J L Rodda, and K P Klugman
Paediatric Infectious Disease Unit, Soroka University Medical Centre, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008587 Meningitis, Viral Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Viral Meningitis,Meningitides, Viral,Viral Meningitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338

Related Publications

R Dagan, and L Velghe, and J L Rodda, and K P Klugman
November 1993, The Journal of antimicrobial chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
June 1991, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
November 1984, Antimicrobial agents and chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
January 1987, Infection,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
January 2000, Antimicrobial agents and chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
November 1983, The Journal of antimicrobial chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
March 1980, The Journal of antimicrobial chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
September 1986, Antimicrobial agents and chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
April 1992, The Journal of antimicrobial chemotherapy,
R Dagan, and L Velghe, and J L Rodda, and K P Klugman
July 1990, Neurochirurgia,
Copied contents to your clipboard!